Abstract

GONZALEZ-ESCANDON, Jared et al. Statins, an Alternative in the Treatment of COVID-19. Rev. Fac. Med. (Méx.) [online]. 2023, vol.66, n.6, pp.7-16.  Epub Mar 01, 2024. ISSN 2448-4865.  https://doi.org/10.22201/fm.24484865e.2023.66.6.02.

Statins are widely used to control cholesterol levels in patients with hypercholesterolemia, which helps prevent cardiovascular diseases. In addition to controlling endogenous cholesterol synthesis, statins have diverse pleiotropic effects, such as anti-inflammatory, antioxidant, and immunomodulatory properties. The disease caused by the SARS-CoV-2 virus (COVID-19) causes a cytokine storm that contributes to the generation of acute respiratory syndrome, which can lead to severe symptoms of this disease and even the death of the patient. Various studies carried out on patients with COVID-19 who received statins, before or during the disease, registered less severe symptoms, shorter hospital stays and lower mortality. The benefit of statins in COVID-19 should be explored more widely, as they can potentially contribute to the control of this pandemic that has devastated humanity.

Keywords : Statins; COVID-19; inflammatory mediators; atorvastatin.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )